NANOG and breast carcinoma: In breast cancer, ALKBH5 expression is induced by hypoxia‐inducible factor 1α (HIF1α) and HIF1β, and its overexpression under hypoxic conditions reduces NANOG mRNA methylation levels, increasing the number of breast cancer stem cells.53